Looking to publish in Translational Lung Cancer Research? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowTranslational Lung Cancer Research is an international, peer-reviewed, open-access journal indexed by Science Citation Index Expanded (SCIE) and PubMed/PubMed Central, focusing on cutting-edge development on the transition from preclinical to clinical research, including but not limited to multimodality therapy, markers, imaging, tumor biology, pathology, chemoprevention, and technical advances related to lung cancer and relevant thoracic diseases.
Looking to publish in Translational Lung Cancer Research? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowSubmission Instructions
Translational Lung Cancer Research accepts the following article types. Click on an article type to view submission instructions.
Original Article
Review Article
Systematic Reviews Without Meta-Analysis
Narrative Review (Also Called Literature Review)
Scoping Review
Clinical Practice Review
Mini-Review
Clinical Practice Guideline
Expert Consensus
Case Series
Case Report
Brief Report
Letter To The Editor
Recent Publications
B cell-driven refractory hemocytopenia in immune checkpoint inhibitor therapy: a report of two cases
Feng Li, Chunyan Wang, Guohua Yao, Shaotong Zhang, Qian Hu, Zhenyu Ju, Wenhua Liang
Integrated management of immunotherapy and radiotherapy for patients with metastatic non-small cell lung cancer: a narrative review of current landscape and future directions
Xinquan Liang, Fengxue Li, Yingying Zhang, Pingping Hu, Tiantian Tian, Yan Zhang, Ning Liang, Guodong Deng, Fangjie Ding, Xin Liu, Lili Qiao, Jiandong Zhang
Adjuvant chemotherapy for completely resected stage IB–IIA non-small cell lung cancer according to the AJCC 8th edition staging system: a real-world retrospective cohort study based on the SEER database
Zewen Sun, Changtai Zhao, Kexin Feng, Geyun Chang, Jingwei Zhang, Yan Ju, Fan Yang, Xiang Yan, Xiao Li
Effect of cold ischemia time and storage temperature on anaplastic lymphoma kinase (ALK) expression in surgically resected lung cancer specimens
Ryuichi Yoshimura, Naoki Yanagawa, Noriyuki Yamada, Makoto Tomoyasu, Wataru Shigeeda, Yuka Kaneko, Ryotaro Endo, Hironaga Kanno, Hiroyuki Deguchi, Hajime Saito
A radiomics nomogram integrated with radiological features for preoperative prediction of lung nodule invasiveness: comparison with Lung-RADS
Siwei Miao, Zhaojie Han, Fei Wang, Shengwei Liu, Ying Li, Kun Li, Hongqian Wang, Shuaixiang Gao, Xiaolin Xiong, Hao Luo, Chencui Huang, Yang Qiu, Peng Wang, Haidong Wang
Frequently asked questions
How long does it take to publish?
In-house review takes 1-3 weeks. External peer review takes 1-3 months. Publication ahead of print occurs within 1 month after acceptance with APC payment received. Formal publication occurs within 1-3 months after acceptance with APC payment received. Original Articles are listed as priority.
Reformat to Translational Lung Cancer Research using Livewrite PremiumIs a cover letter required?
Authors must disclose any use of AI tools in the cover letter, Materials and Methods, and Acknowledgment.
Reformat to Translational Lung Cancer Research using Livewrite PremiumWhat are the publication costs?
Article processing charges apply.
Reformat to Translational Lung Cancer Research using Livewrite Premium